Predictors of long‐term mortality with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block
Open Access
- 30 October 2018
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 41 (10) , 1358-1366
Abstract
Background: Cardiac resynchronization therapy (CRT) is highly beneficial in patients with heart failure (HF) and left bundle branch block (LBBB); however, up to 30% of patients in this selected group are nonresponders.Hypothesis: We hypothesized that clinical and echocardiographic variables can be used to develop a simple mortality risk stratification score in CRT.Methods: Best‐subsets proportional‐hazards regression analysis was used to develop a simple clinical risk score for all‐cause mortality in 756 patients with LBBB allocated to the CRT with defibrillator (CRT‐D) group enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy. The score was used to assess the mortality risk within the CRT‐D group and the associations with mortality reduction with CRT‐D vs implantable cardioverter defibrillator (ICD) in each risk category.Results: Four clinical variables comprised the risk score: age ≥ 65, creatinine ≥ 1.4 mg/dL, history of coronary artery bypass graft, and left ventricular ejection fraction (LVEF) < 26%. Every 1 point increase in the score was associated with 2‐fold increased mortality within the CRT‐D arm (P < 0.001). CRT‐D was associated with mortality reduction as compared with ICD only in patients with moderate risk: score 0 (HR = 0.80, P = 0.615), score 1 (HR = 0.54, P = 0.019), score 2 (HR = 0.54, P = 0.016), score 3‐4 risk factors (HR = 1.08, P = 0.811); however, the device by score interaction was not significant (P = 0.306). The score was also significantly predictive of left ventricular reverse remodeling (P < 0.001).Conclusions: Four clinical variables can be used for improved mortality risk stratification in mild HF patients with LBBB implanted with CRT‐D.Keywords
Funding Information
- Boston Scientific Corporation
This publication has 30 references indexed in Scilit:
- Prediction of Mortality in Clinical Practice for Medicare Patients Undergoing Defibrillator Implantation for Primary Prevention of Sudden Cardiac DeathJACC, 2012
- Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)Circulation, 2011
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart FailureNew England Journal of Medicine, 2010
- Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony☆European Journal of Cardio-Thoracic Surgery, 2010
- Applied Survival Analysis (2nd Edn.). D. Hosmer, S. Lemeshow, and S. May (2008). Hoboken: Wiley Series in Probability and Statistics. ISBN: 978‐0‐471‐75499‐2Biometrical Journal, 2009
- Severe Left Ventricular Dyssynchrony Is Associated With Poor Prognosis in Patients With Moderate Systolic Heart Failure Undergoing Coronary Artery Bypass GraftingJACC, 2007
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical ProtocolAnnals of Noninvasive Electrocardiology, 2005
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Clinical classification of cardiac deaths.Circulation, 1982